IONIS PHARMACEUTICALS INC (IONS:NASDAQ)
$75.26 -1.56 (-2.0307%)
Analysed IONIS PHARMACEUTICALS INC (IONS:NASDAQ) News Sources
Ionis to hold first quarter 2026 financial results webcast
15-04-2026
yahoo.com
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
13-04-2026
yahoo.com
Nike downgraded, IBM initiated: Wall Street's top analyst calls
10-04-2026
yahoo.com
Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says
09-04-2026
yahoo.com
Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza
31-03-2026
yahoo.com
FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story
28-03-2026
yahoo.com
Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report?
27-03-2026
yahoo.com
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
26-03-2026
fool.com
Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 to $106
26-03-2026
247wallst.com
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug
24-03-2026
yahoo.com
What is the current price of IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The current price of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is $75.26.
IONIS PHARMACEUTICALS INC (IONS:NASDAQ) absolute price change since previous trading day?
The absolute price change of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) since the previous trading day is $-1.56.
IONIS PHARMACEUTICALS INC (IONS:NASDAQ) percentage price change since previous trading day?
The percentage price change of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) since the previous trading day is -2.0307%.
What is the most recent average sentiment score for IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The most recent average sentiment score for IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The most recent sentiment for IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is .
SEC-8K** Filing Available For IONIS PHARMACEUTICALS INC (IONS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.